Bent Frandsen

(Mr. Bent Frandsen)

Currently holds a position at ExpreS2ion Biotech Holding AB

Positions

Position Company Period
Chief Executive Officer ExpreS2ion Biotech Holding AB Dec. 20, 2019 -
Chief Business Officer ExpreS2ion Biotech Holding AB Aug. 1, 2018 - Dec. 20, 2019
Vice President Business Development ExpreS2ion Biotech Holding AB Jan. 1, 2016 - Aug. 1, 2018
Bent Frandsen's trades of ExpreS2ion Biotech Holding AB's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-04-17 2023-04-17
B Purchase
10,366
4.90
SEK 4,937 		10,366 4.90 SEK 50,793
2023-04-17 2023-04-14
B Purchase
12,665
4.90
SEK 6,038 		12,665 4.90 SEK 62,059
2023-04-17 2023-04-14
B Purchase
70,665
4.90
SEK 33,691 		70,665 4.90 SEK 346,259
// ... existing code ... // ... rest of the file ...